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Disorders of Transepidermal Elimination 
Part 2 
THOMAS Y. Woo, M.D., AND JAMES E. RASMUSSEN, M.D. 
ransepidermal elimination is  a disorder in which T dermal stimuli profoundly effect the behavior 
and structure of the overlying epidermis. Briefly, 
there are two categories of disorders: the first are 
primary dermatoses and consist of elastosis perforans 
serpiginosa and reactive perforating collagenosis; the 
second group originates from alterations of dermal 
constituents in preexisting disorders which induces 
transepidermal elimination. Some examples are per- 
forating granuloma annulare, pseudoxanthoma elas- 
ticum, sarcoid, lichen nitidus, and several others. The 
following is a review of the latter group. 
Perforating Granuloma Annulare 
Granuloma annulare (GA) is a benign granuloma- 
tous skin disorder consisting of flesh-colored papules 
arranged in an annular or arciform pattern. Histologic 
features include focal areas of altered "necrobiotic" 
collagen surrounded by palisading mononuclear 
phagocytes. Several subtypes of this disorder exist 
including subcutaneous varieties. Recent articles have 
emphasized the other variants, such as generalized 
perforating GA',' and perforating GA.3,4 
History 
Perforating GA (PGA) was initially described by 
Pinkus in 19345 and then nearly two decades later 
by Civatte' in 1952 in five patients who were given 
the erroneous diagnosis of tuberoulcerative or gum- 
matous GA. Calnan' presented another patient in 
1954. The present concept of TE in PGA was not 
fully elucidated until 1971, when OwenB described 
two patients with small nodular lesions with central 
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umbilication on the margins of the fingers and on 
the hands. 
Clinical Characteristics 
We have reviewed 22 cases of PGA described in 
the literature (Table 1). The average age of onset was 
29 years, with a ferna1e:male ratio of 16:6. Most 
lesions were described as flesh- or red-colored, 
asymptomatic, 3-4-mm papules with central umbili- 
cation. Most (95%) occurred on the extensors of the 
extremities, especially on the dorsa of the hands. 
Other sites included the face, back and shoulders. 
The Koebner phenomenon was not noted. While 
most reports specifically reported sparing of the palms 
and soles, one presents the unique appearance of 
round, grouped papules with a 2-8-rnm central um- 
bilication present on the palms.g Another describes 
lesions on the soles.'o Usually the papules of PCA 
do not drain, but two patients' lesions have been 
shown to exude a thick, creamy7 or cheesy" material. 
individual lesions resolve over months, leaing a hyper- 
or hypopigmented area, but the disease may continue 
for many months. Although a recent review suggests 
that diabetes may be associated with GA," only 
three of the reported cases of PCA, were in patients 
with diabete~.'.~,~~ 
Histology 
At a single time, only a few papules are in the 
active state of perforation; therefore, serial sections 
on several lesions must be performed or the diagnosis 
may be mis~ed.'~-'' Examination of the epidermal 
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FIG. 1. Lesions of perforating granuloma annulare (PCA) are 
seen as umbilicated papules on the dorsa of the hand. Note that 
there is not a strict linear pattern to the configuration. 
perforating canal with special stains shows a plug 
consisting of cellular debris, altered collagen, and 
mucinous material. The epidermal perforation com- 
municates with small areas of GA in the dermis that 
consist of altered ("necrobiotic") collagen surrounded 
by pallisading mononuclear phagocytes in the dermis. 
The necrobiotic area is superficial in the papillary 
dermis and can be seen to form the floor of the canal 
as the altered collagen is actively extruded. 
Generalized Perforating Granuloma Annulare 
Generalized PGA was first described by Duncan 
et aI.l3 in two children with multiple flesh-colored 
papules on the extensors of the extremities, many of 
them with a central dell, some with a tiny central 
scab. The papules were 1-4 mm in diameter and 
regressed spontaneously. Since this initial report, there 
have been at least seven patients described (Table 
2).1*2.13-16 There are probably five additional cases of 
generalized PGA from the given clinical description, 
but TE could not be substantiated because histologic 
serial sections were not perf~rmed.'~ The average 
age of onset was 17 years. Most patients have 
hundreds of lesions, often numbering greater than 
300 flesh- to rust-colored  papule^,'^'^*'^ usually 3-4 
mm in diameter, with ombilicated crusted centers. 
Initially, some skin-colored to red papules appear 
and are associated with erythematous ha10s.l~ These 
increase in size and develop a yellowish center with 
a central umbilication. The course is similar to that 
of localized PGA. The extensors of the extremity are 
the most common site. Rarely, the cheeks, face, 
interscapular region, and pinna of the ear may be 
involved. The palms and soles usually are not affected. 
Three of the patients specifically noticed exacerbation 
of the eruption during the summer, and one of these 
reported total clearing during the winter.13,14 Two of 
the patients reported p r u r i t u ~ ~ , ' ~  and only one patient 
reported the presence of diabetes." 
lransfollicdar Elimination of Granuloma Annulare 
Bardachl7,l8 described two patients, a 42-year-old 
woman in good health and a 68-year-old diabetic 
man, both with asymptomatic red papules, on the 
hands in the former and on the neck, upper chest, 
and shoulders in the latter. Histologic examination 
revealed elimination of necrobiotic material via the 
follicular epithelium from an adjacent pallisading 
granuloma. 
Association with Other Disorders 
There is no evidence to associate PGA with internal 
disease, although of the 29 patients with generalized 
and isolated PGA described in the literature, four 
had diabetes m e l l i t ~ s , ~ ~ ~ * ~ ~ , ' ~  two had pulmonary tu- 
be rcu l~s i s ,~~ '~  one had progressive neural atrophy," 
one had Down's syndrome," and another 7-9% 
eo~inophilia.'~ Dick and Syme reported a case of 
PGA in association with scleritis, with concurrent 
onset and resolution of both  disorder^.^ An interesting 
observation by Aliaga et aL3 and Carton et aI.*' 
concerns their patients who had been consuming 
vitamin D prior to the occurrence or reappearance 
of PCA. Aliaga's patient had been ingesting vitamin 
D 600,000 IU/week for a total of 2 years. Twelve 
papules of PGA appeared on the dorsa of his fingers. 
No Koebner phenomenon was seen. Discontinuation 
of the vitamin resulted in complete clearing within 
40 days.3 
PCA is a disease of unknown etiology, although 
the basic pathogenesis of GA has been postulated to 
involve immune complexes4 with participation of the 
helper-inducer T cell subset." Several pathogenic or 
precipitating factors have been implicated, including 
insect bites,8 ultraviolet ~adiation,'~"~ vitamin D ad- 
mini~tration,~**' and trauma." Smith and Goette15 
attempted to induce lesions experimentally in their 
patients with liquid nitrogen, cantharidin, needle 
pricks, and ultraviolet light A and B, with no success. 
This experimental evidence and the fact that the 
majority of reports specifically deny the presence of 
the isomorphic response strongly suggest that sunlight 
and trauma have very little to do with the pathogen- 
esis of this disorder. 
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TABLE 1. Perforating Granuloma Annolare 











































































3-4-mm papules on extensors of extremities, 
dorsa of wrists and fingers (10 of 60 
lesions umbilicated) 
3-4-mm papules on dorsa of fingers, 12 in 
10-15 papules (3-4 mm) with central 
3-5-mm papules with central umbilication on 
26 umbilicated papules on hands 
3-5-mm papules 
3-5-mm papules on hands 
number, central umbilication 
umbilication on fingers 
face and hands 
2-8-mm papules with central umbilication on 
extensors of extremities and palms 
Skin-colored with urnbilication on dorsum of 
Typical appearance on hands and fingers 
Extensors, back, shoulders involved 
Red papulo-nodules 
Symmetric on trunk and limbs with atrophic 
hands 
scars 
Bluish-red plaque on flexor of wrist with 
many plugged and crusted sinuses, 
discharging cheesy material 
5-mm red nodules with ulceration then small 
scars. Some heal with scars. 
Symmetric eruption of small nodules on 
backs of hands and fingers, pale lilac tint 
with central plug, without scars. 
Discharges creamy, thick fluid. 
Face 
Several cases of perforating CA 
Topical steroids helped 
Stopped intake of vitamin D with 
complete resolution 
Resolved in 6 months 
Fluminolone induced remission 
in 1 month 
Good response to topical steroids 
Treated with chloroquine, sulphur, 
dapsone, and anti-tuberculous 
drugs without effect 
Resolution in 2 years without 
treatment. Associated and 
resolved simultaneously 
with scleritis. 
Diagnosis lesions i s  slow, sometimes taking years, compared 
with 1-2 months in RPC. The histology of PGA is 
The disease that most nearly rnimicks the appear- also characteristic with TE of a central necrobiotic 
ance and location of PGA is reactive perforating mass with peripheral phagocytes. Furthermore, there 
collagenosis. Clinically, PGA (in contrast to RPC) is are no vertically oriented collagen fibers (which can 
not associated with the Koebner phenomenon. PGA be seen in RPC). At the base and adjacent areas of 
tends to occur a decade later and is not closely PGA lesions are the typical histologic picture of GA. 
associated with diabetes. Resolution of individual Histology excludes other disorders with a similar 
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FIG. 2. The typical histology of granuloma annulare can be 
seen at the base of a lesion of perforating grannuloma annulare. 
This patient also had concurrent Henoch-Schonlein purpura. (X100) 
(Courtesy of Donald Clemons, M.D.) 
clinical appearance, such as Kyrle's disease, EPS, 
keratocanthoma, pityriasis lichenoides et varioliformis 
acuta, and molluscum contagiosum. 
Jrea tmen t 
Treatment of this disorder has consisted of topical 
steroids with occlusion, which have helped consid- 
erably in some  patient^^,'^*^^ but not in others.' Oral 
prednisone induced remission within 1 month with 
no recurrences in one patient (total dose, 500 mg).'O 
Topical treatments found to  be unsuccessful include 
topical steroids without occlusion,2' salicylic acid: 
and liquid nitr0gen.9,'~ Other unsuccessful agents 
included chloroquine, sulfur, dapsone, and antitu- 
berculous agents,'' ultraviolet light'5*'9 vitamin Bb, 
and iodobi~mitol.'~ Spontaneous remission may also 
occur.'3 
Transepidermal Elimination of Sarcoidal 
Granulomas 
Another example of TE of granulomas was reported 
by bat re^.^^ A 24-year-old black man with a diagnosis 
of sarcoidosis had TE discovered during a routine 
chest x-ray. It was confirmed on biopsy of mediastinal 
nodes. On examination, he had similar-appearing 
lesions present on the scalp, cheek, and mandible. 
Lesion sizes ranged from 5.6 cm on the scalp to 0.8 
cm on the mandible. Biopsy examination of the scalp 
showed several sarcoid granulomas composed of 
epithelioid cells scattered throughout the dermis. The 
more superficial granulomas were in contact with the 
epidermis, with resulting pseudoepitheliomatous hy- 
perplasia. Portions of the granuloma were seen to be 
engulfed by the epidermis, while another portion 
appeared within a cup-shaped depression at the 
surface of the epidermis. These findings were consis- 
tent with TE of sarcoidal granulomas. 
Perforating Pseudoxanthoma Elasticum 
Pseudoxanthoma elasticum (PXE) is a genetically 
inherited generalized disorder of connective tissue 
considered to be divided into two autosomal domi- 
nant (AD) and two recessive (AR) variants. This sys- 
temic disease is characterized by childhood onset 
and involves the eyes with angioid streaks, gastroin- 
testinal tract, cardiovascular system, and the skin. 
Cutaneous findings include groups of small, yellow 
papules in the flexural folds, especially involving the 
neck, axillae, groin, antecubital fossa, and umbilicus. 
History 
The earliest case of perforating PXE occurred in 
1962, when S ~ h u t t ~ ~  reported a 33-year-old man with 
PXE and a 1-year history of a persistent papular 
eruption. The patient had closely grouped, brown, 
discrete, hyperkeratotic papules aggregated in the 
left axillae and 3 cm above the umbilicus. Although 
Schutt considered this a case of "reactive perforating 
dastosis" (EPS) occurring in a patient with PXE, it 
was later shown by Lund and Gilbert24 to be the first 
definite case of perforating PXE. 
Clinical Characteristics 
To date, there have been at least 18 cases of 
perforating PXE reported in the literature. Table 3 
lists the cases and describes the salient features of 
The youngest individuals were 16- and 17- 
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TABLE 2.  Generalized Perforating Granuloma Annuhe 
Age of 
Presentation Onset Size 
Author (Yrs.) Sex Yrs. Site No. (mm) Description Diabetes Course 
Hazelrigg’ 19 F 
Duncan” 3 M 
6 F 
Izumi” 6 F 
lacyk” 42 F 
Bauman’ 6 F 








Knees to dorsa feet 
Extensors of extremities 
Extensors of extremities, 
sparse on back 
Sun exposed extensors 
of extremities, rarely 
on trunk 
Extensors of extremities, 
face, interscapular, 




Extensors of lower 
extremities, calf but 
sparsely all over, 
sparing palms, soles 
and face 
500 1 Rust and flesh colored with 
umbilicated crusted 
centers, other flat and 
shiny. Down‘s 
syndrome. 
50 1-2 Flesh colored papules with 
central deli or scab with 
occasional macules and 
scars. Erythematous halo 
with moderate pruritus. 
50 3-4 Similar to above. 
300 1-3 Papular lesions, one third 
umbilicated. 
500 3-5 Erythematous papules with 
central umbilication with 
discharges clear fluid. 
Many 5 Flesh colored papules with 
umbilication, no 
discharge. 
Many Small Red papules with yellow 
center with discharge of 
clear fluid. 















TABLE 3. Summary of Cases of Perforating Pseudoxanthoma Elasticum 
Diminished 
Pulses or Location 
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TABLE 4. Comparison of Clinical Properties of Autosornal Dominant and Recessive-type PXE36 
Dominant 1 : Dominant 2: Recessive 1 : Recessive 2: 
Characteristics # of Patients (96) # of Patients (%) # of Patients (%) # of Patients (%) 
Classical, peau dorange and 
flexural rash 
hcutar  rash 
























year-old men, the rest were older than 30 years of 
age. The average age of onset was 43 years in 14 
women and 4 men. Most patients were black or of 
Mediterranean origin. Periumbilical location of the 
lesions occurred in 89% of the patients; less frequent 
sites were the sides of the neck, upper arm, anterior 
chest, axillae, groin, and back. The typical clinical 
appearance of perforating PXE consists of closely 
clustered, well-demarcated, soft, brown, hyperkera- 
totic papules in a periumbilical location.28 Several 
papules may coalesce into a tender verrucous plaque, 
up to 14 cm in size, with hyperkeratotic papules at 
the periphery. Occasionally "purulent" material may 
exude from the border of the plaque.26 Infrequently, 
a well-demarcated, hyperpigmented, reticulated, 
atrophic patch with discrete, scattered, keratotic pap- 
ules at the periphery of the lesion may occur.29 
Pruritus is a variable feature. As opposed to other 
perforating dermatoses, perforating PXE is typically 
characterized not by discrete umbilicated papules, 
but by clustered keratotic papules at the periphery 
of a verrucous plaque. Only three patients had um- 
bilicated 
Vascular disease, such as hypertension, claudica- 
tion, diminished pulses, or angina, were found in 11 
(61%) patients with perforating PXE. Angioid streaks 
were reported in 4 patients (220/0), while 12 patients 
(67%) were stated specifically not to have angioid 
streaks. Considering the AD and AR forms (types 1 
and 2 )  of PXE as defined by Pope,36 vascular disease 
is not a feature of the AD type 2 nor AR type 1 or 2 
(less than 20%). On the other hand, vascular disease 
occurs in 75% and angioid streaks in 34% of individ- 
uals with Pope's AD type 1 (Table 4). In this respect, 
patients with perforating PXE most closely resemble 
Pope's AD type 1 in regard to vascular and ocular 
involvement. 
Histology 
Lund and Gilbertz6 have succinctly and clearly 
differentiated perforating PXE from EPS that occurs 
in association with PXE. Histologically, PXE is a distinct 
entity characterized by mild acanthosis with basophilic 
elastic fibers in the midreticular dermis with an ad- 
jacent foreign body reaction. The elastic fibers are 
curled, granular, fragmented, and calcified. Accord- 
ingly, perforating PXE is characterized and differs 
from EPS by the presence of short, gnarled, calcified, 
basophilic elastic fibers that are being transepidermally 
eliminated.26 Idiopathic EPS, on the other hand, is 
characterized by straight noncalcified eosinophilic 
elastic fibers (except in elastomas) and is not asso- 
ciated with any systemic involvement. Lund and 
Gilbert reviewed the literature and found that only 
one case reported as EPS in association with PXE 
clearly established the presence of the two diseases. 
Furthermore, this single case had unusual features 
not typical of EPS. In addition, one other case that 
they did not include did not establish the presence 
of EPS in a patient with documented PXE.37 It i s  
probable that almost all cases reported as EPS occur- 
ring in patients with PXE are actually perforating PXE. 
Since the publication of Lund and Gilbert's paper, 
there have been no reported cases of EPS in associ- 
ation with PXE, as all subsequent reports have been 
described as perforating PXE. 
Transepidermal Elimination of lichen Nitidus 
An otherwise healthy 8-year-old boy with an 
asymptomatic rash on the trunk and extremities of 
several months duration was reported by Barda~h.~' 
Close inspection disclosed multiple pin-sized, round, 
flesh-colored, shiny papules distributed over the arms, 
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trunk, and legs favoring the extensor surfaces. Biopsy 
from an elbow lesion showed characteristic features 
of lichen nitidus. However, serial sectioning revealed 
the presence of a discrete dermal infiltrate lying at 
the base of a transepidermal perforating channel, in 
communication with the surface. 
Transepidermal Elimination of Papular Mucinosis 
Bard39 recently described a case of TE of papular 
mucinosis. This 50-year-old woman with long-standing 
scleromyxedema, confirmed on previous biopsy, de- 
veloped asymptomatic 1 -2-cm nodules with a central 
adherent keratotic plug within yellow doughy plaques 
on the extensor aspects of her upper extremities. 
These were resistant to treatment. 
On histologic evaluation, the epidermis was acan- 
thotic, hyperkeratotic, and hyperplastic with the for- 
mation of a transepidermal channel filled with alcian 
blue-positive material in direct communication with 
the dermis. The dermis contained fibroblast prolifer- 
ation with intensely eosinophilic collagen bundles 
and was positive on alcian blue stain, indicative of 
acid mucopolysaccharides. These changes were con- 
sistent with TE of mucinous material present in lesions 
of scleromyxedema. 
Perforating Rheumatoid Nodule 
Although transepidermal elimination of rheumatoid 
nodules i s  probably quite common, it was not until 
Horn and Coette4' in 1982, drew attention to this 
interesting phenomenon. Their 54-year-old woman 
patient with rheumatoid arthritis developed periartic- 
ular nodules with a central core. The striking histologic 
feature was TE, with a remarkable depth of extrusion. 
The acanthotic crater traversed the entire thickness 
of the dermis with a column of necrobiotic material 
extending from the deep dermis to the epidermis 
and extruding through the crater. They postulated 
that this was possibly a case of transdermal elimination 
in conjunction with transepidermal elimination. 
Transepithelial Elimination in Necrobiosis Lipoidica 
Parra4' described three cases of adult-onset dia- 
betics with lesions typical of necrobiosis lipoidica, 
mostly on the extremities. Around the periphery of 
the necrobiosis lipoidica lesions were brown, comedo- 
like plugs that could be removed on scraping with a 
curette, leaving a crater-like depression. 
Histologic examination of their biopsies was con- 
FIG. 3. Histology of an umbilicated papule of lichen nitidus 
demonstrating TE. (X250) (Courtesy of Harald G .  Bardach, M.D.) 
sistent with necrobiosis lipoidica, but in all specimens 
examined there was elimination of a band of altered 
"necrobiotic" collagen via a transfollicular route. The 
epidermis was acanthotic and hyperkeratotic. Garcia 
et a1.4* reported a similar condition. 
Parra postulated that the process of transepithelial 
elimination through the follicular wall may lead to 
the destruction of the hair follicle. This in turn may 
explain the absence of epidermal appendages, which 
is a common finding in long-standing necrobiosis 
lipoidica. 
Transepithelial Elimination of Infectious Agents 
and 
Several examples of TE of bacterial,43 protozoal," 
pathogens have been reported in the 
FIG. 4. TE of staphyloccal aureus in botryomycosis. (XlOO) 
(Courtesy of Detlef K. Coette, M.D.) 
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Fffi. 5. Calcinosis cutis following electroencephalography using 
a calcium containing electrode paste. Note TE of the calcium 
particles. (X100) (Courtesy of Amir H. Mehreghan, M.D.) 
literature. G~et te , '~  a prominent figure in the field of 
TE, recently described a case of botryomycosis (ac- 
tinophytosis due to staphylococcal aureus) in a 76- 
year-old man with a clinical lesion that appeared as 
a basal cell carcinoma with a central erosion. Wood 
et al." reported a 33-year-old man with neurologic 
symptoms secondary to schistosomiasis who devel- 
oped flesh- and erythematous-colored papules ar- 
ranged in an arcuate configuration. A biopsy specimen 
revealed schistosomal ova within dermal granulomas 
perforating through the epidermis. Biopsy specimens 
from both patients revealed TE of the infectious 
agents. with pseudoepitheliomatous hyperplasia of 
Fffi. 6. The transepidermal channel containing calcium is 
easily demonstrated in this histopathologic section from a perforating 
calcified nodule. (XlOO). (Courtesy of Dennis A. Weigand, M.D.) 
the epithelium, with tongues of epithelium surround- 
ing and engulfing the bacterial and protozoal organ- 
isms, respectively. They were then seen to be elimi- 
nated through a transepidermal channel to the surface. 
It has also been suggested that TE of fungal spores 
(Medlar bodies) may occur as a regular phenomenon 
in cutaneous c ~ ~ o ~ o ~ ~ c o s ~ s . ~ ~ ~ ~ "  
Transepithelial Elimination of Nevocellular Nevus 
and Malignant Melanoma 
The first report of a nevus exhibiting the phenom- 
enon of TE was reported by Rupe~,~ '  who described 
a large series of junctional nevocellular nevi in which 
TE of junctional nests could be demonstrated in 8 of 
65 lesions. Later, Rupec et aL4' reported a similar 
large series of 52 female and 18 male patients, aged 
2-49 years, with benign juvenile melanoma (Spitz's 
nevus). He found only one case with TE of Spitz's 
nevus cell nests in his series. 
The first North American report of perforating 
melanoma was published by C0ette,4~ whose 56- 
year-old woman patient presented with a nodular 
melanoma on the right calf. The epidermis in the 
center of the lesion was characterized by pseudoepi- 
theliomatous hyperplasia and formed a perforating 
channel filled with melanoma cells. Goette did not 
state the incidence of TE seen in malignant melanoma 
but postulated that TE may be a mechanism of 
eliminating malignant cells from the skin, as opposed 
to the commonly observed epidermal erosion seen 
over many malignant tumors. 
Gartann et aLS0 reviewed the phenomenon of 
perforating nevi and malignant melanoma in a recent 
article. They found that in malignant melanoma, 
tumor cells occurred quite frequently within the 
stratum corneum. In contrast, TE of nevus cells rep- 
resented a very rare phenomenon that occurred in 
only 0.1 3% of active nevocellular nevi. They thought 
that TE of nevus cells, however, did not reflect 
malignant degeneration. 
Transepidermal Elimination of Calcium- 
containing Material 
TE of calcium-containing material has been reported 
in several instances. Weiner, in 1952, drew attention 
to this phenomenon in which TE of calcium occurred 
in a solitary congenital nod~ le .~ '  Later, Schoenfeld et 
aL5* reported four cases of calcium deposition in the 
skin following electroencephalography. Histology 
performed in three cases showed TE of calcium via 
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a transepidermal or transfollicular route. An underlying 
mild granulomatous reaction was present in all pa- 
tients. 
Weigands3 reported a 15-year-old black man who 
presented with a 3-month history of a hard, superficial, 
pale yellow, dome-shaped nodule, 5 rnm in diameter 
and 2 mm high on the right infraorbital fold. Histologic 
examination of this lesion revealed a subepidermal 
calcified nodule with apparent origin in the hair 
follicles. Seen also on the histologic sections was the 
presence of calcium deposits in the upper dermis, 
scattered in the epidermis in an area of epithelial 
hyperplasia and in the stratum corneum. The pro- 
gression of dermal calcium deposits in an ascending 
fashion through the epidermis suggested TE. Eng and 
Mandrea, in 1961,54 described two children who 
presented with milia-like lesions in the pubic and 
groin area. Biopsy of these lesions showed TE of 
calcium deposits perforating through the epidermis, 
with the surrounding epithelium hyperplastic. 
Transepidermal elimination of idiopathic primary 
cutaneous ossification or osteoma cutis has been 
reported mostly in the French literature. Several cases 
demonstrated TE of bony fragments on histologic 
examination, with formation of hyperplastic tongues 
of epidermis surrounding a focus of bony fragments. 
Subsequent engulfment resulted in transportation and 
elimination of these fragments from the dermi~.~ ’ -~ ’  
Perforating Porokeratosis of Mibelli 
Porokeratosis of Mibelli is a distinct genodermatosis 
consisting of a plaque with a raised border containing 
a central furrow, the coronoid lamellae. The entity of 
perforating porokeratosis of Mibelli is in dispute; only 
two reports have described this entity thus far.58,59 
These reports present a 51 - and a 68-year-old woman 
with classical lesions of porokeratosis of Mibelli with 
no clinical suggestion of a perforating disorder. Biopsy 
specimens from both patients revealed the coronoid 
lamellae in opposition to the dermis, the normally 
intervening basal cells being absent in some areas. 
On biopsy, one patient also demonstrated the pres- 
ence of amorphous material that extended from the 
dermis, through the breach in the epidermis, and 
upward to the s~rface.’~ Masson’s trichrome stain 
confirmed that the perforating material was collagen. 
Miscellaneous Conditions 
The exact nosologic position of the following en- 
tities is uncertain at this time but mention should be 
given in this discussion of disorders of TE. Boven- 
meyep  reported TE of eruptive vellus hair cysts in a 
9-year-old who had multiple, asymptomatic umbili- 
cated flesh-colored papules on the sternal area. Hy- 
land and KheiP’ described a patient with long-stand- 
ing hidradenitis suppurativa in whom biopsy of the 
sinus tracts and ulcers showed TE of abnormal elastic 
tissue (a histologic finding initially thought to be 
specific for EPS). Their patient differed from EPS 
because of the absence of the typical clinical and 
histologic picture of EPS. 
Although traditionally thought of as primary disor- 
ders of transepithelial elimination:* perforating follic- 
ulitis and Kyrle’s disease are not disorders of TE in 
the strictest sense. Perforating folliculitis was first 
described in 196863 and was immediately recognized 
as a common disorder. The clinical appearance con- 
sists of multiple erythematous papules, 2-8 mm in 
diameter, with a central keratinous plug that can be 
removed easity. Papules are almost always follicular 
and do not coalesce. Distribution of lesions are 
limited to the arms, thighs, and buttocks. The histology 
centers around a curled hair that is almost always 
present (serial section must be performed). The hair 
may induce areas of rupture of the infundibular 
epithelium into the dermis. At the sites of rupture, a 
focal inflammatory infiltrate containing altered colla- 
gen and elastic fibers (that have lost their orceinophilic 
staining properties and therefore stain brightly eosin- 
ophilic) can be seen. This focus of inflammation and 
degeneration is then surrounded by reactive prolif- 
erating follicular epithelium and is thus moved upward 
into the follicular cavity and eventually eliminated. 
Since the initial event is rupture and release of 
irritating follicular contents into the dermis, and not 
primary elimination of abnormal connective tissue 
components or foreign bodies, this disease should 
not be considered a primary disorder of TE.64 
Kyrle’s disease was first described in 191665 in a 
healthy 22-year-old white woman with asymptomatic, 
generalized, papular eruption located primarily on 
the extremities. Kyrle termed this new disorder “hy- 
perkeratosis follicularis et parafollicularis in cutem 
penetrans.” Early lesions are pin head size with a 
silvery scale. Subsequent enlargement to a 3-4-mm 
hyperkeratotic papule with a central, large cone- 
shaped plug occurs. Location i s  both follicular and 
perifollicular and lesions can appear as confluent 
polycyclic plaques when on the extremities. Constan- 
tine and Carterb6s6’ reviewed the literature and ex- 
cluded many reported cases of Kyrle’s on the basis 
of strict clinical and histologic criteria. They used the 
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following clinical criteria: (1 ) chronic, scattered, gen- 
eralized, papular eruption with hyperkeratotic cone- 
shaped plugs; (2 )  lesions are both follicular and 
perifollicular; (3) lesions may coalesce into hyperker- 
atotic verrucous plaques; and (4) lesions are not 
present on the palms and soles and do not involve 
the mucous membranes. In addition, their cases had 
to satisfy rigid histologic criteria, including: (1) a 
hyperkeratotic plug filling an epithelial invagination; 
(2) parakeratosis within the plug; (3) basophilic cellular 
debris (not staining with elastic tissue stains) within 
the plug; and (4) parakeratotic or abnormal keratini- 
zation of all the epidermal cells, including the basal 
cells, in at least one region deep to the plug. In this 
region, epidermal disruption occurred, resulting in a 
foci of keratinized cells in the dermis, producing a 
granulomatous reaction. Kyrle's disease differs from 
perforating folliculitis by its rarity, the presence of a 
perifollicular location, and ability to coalesce into 
verrucous plaques-features that are absent in per- 
forating folliculitis. Furthermore Kyrle's disease i s  
thought to be a defect in the keratinization process, 
which composes the keratotic plug.67 This may be 
the result of a clone of abnormal cells that may 
proliferate at a faster rate than the adjacent normal 
keratinocytes. Abnormal growth results in premature 
and abnormal keratinization within the clone. In the 
majority of cases this is followed by disruption of the 
epidermis into the dermis with the release of highly 
irritating keratin. The presence of this foreign material 
evokes a granulomatous foreign body reaction. 
Therefore, since the initial pathogenic event in Kyrle's 
appears to be an epidermal mutant clone with sub- 
sequent introduction of irritant material into the 
dermis, this, along with perforating folliculitis, appears 
not to be a disorder of TE. Furthermore, Mehregan 
considers most if not all cases of Kyrle's disease to 
be cases of perforating folliculitis.68 
Experimental Evidence 
Transepidermal elimination was studied extensively 
by Bayoumi et al.,69 who injected charcoal particles 
subepidermally into guinea pig flank skin. Elimination 
of the particles via the epidermis occurred in 4 days. 
Histologically, the hair follicles became hyperplastic 
and at times participated in the phenomenon with 
transfollicular elimination. They noted that this reac- 
tion had some similarities to experimental wound 
healing and concluded that TE would occur only if 
the offending material was neither strongly irritant 
(which would cause epidermal necrosis) nor com- 
pletely nonirritative (or else there would be no dermal 
reaction). Furthermore, they concluded that: (1) the 
most "sensitive" zone was located above the level 
of the hair papillae in the dermis; (2 )  increased 
epidermal mitotic activity and active epidermal cell 
movement were involved in the response; and (3) 
the material was expelled via the hair follicle or intact 
epidermis. 
Later in 1980, Bayoumi and Marks7' used the 
guinea pig model and skin explants further to define 
various parameters involved in transepithelial elimi- 
nation. Using various drugs, such as chlorpheniramine, 
cimetidine, indomethicin, and various combinations, 
they found that none of the drugs administered to 
the animals had any effect in preventing the devel- 
opment of TE. Indomethicin, however, diminished 
the epidermal hyperplasia but did not alter the basic 
process. Skin organ studies showed that the initiation 
and development of TE was dependent on the test 
site being in situ in the animal; however, it was also 
apparent that one initiated, TE would continue un- 
abated even in vitro. TE occurred at all the anatomic 
sites tested except the tongue, implying that TE is a 
fundamental epithelial response and not tied to a 
particular type of epidermal maturation or differentia- 
tion. They concluded that TE is not initiated by the 
release of histamines nor prostaglandins, although 
the associated hyperplasia may be partially prosta- 
glandin-dependent." Also, physical distortion of the 
tissue architecture of the skin may be implicated in 
the pathogenesis. 
Conclusion 
Dermal-epidermal interactions have become of 
paramount importance in the field of dermatology. It 
has become clear that dermal stimuli profoundly 
affect the behavior of the overlying epidermis; nu- 
merous examples can be found in the literature. 
Mehregan7' has pointed out three types of epidermal 
reaction to foreign material in the dermis. First, an 
inert material such as hemosiderin will evoke minimal 
or no inflammatory response and therefore little or 
no epidermal reaction. Second, a strongly irritant 
body will evoke a maximal inflammatory and/or 
granulomatous response and, if the reaction is super- 
ficial enough, the subsequent tissue destruction will 
lead to necrosis and epidermal degeneration. Third, 
the subject of this article, is the phenomenon of 
transepidermal elimination. TE i s  a fascinating example 
of dermal-induced epidermal reactive phenomenon 
in which there is a purposeful epidermal response to 
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eliminate the foreign or altered body. This expulsion 
of particulate matter from the dermis into the exterior 
is probably mediated by a complex series of interre- 
lated events. The first event may involve recognition 
of a foreign body by uncharacterized  receptor^.'^ 
Recognition may be followed by the elaboration of 
a substance by dermal components, which induces 
hyperproliferation of the epidermis. The resultant 
formation of perforating channels requires the coor- 
dination of activities such as enhanced epidermal 
growth, cell movement, and phagocytosis by individ- 
ual epidermal cells.70 TE may occur as the basic 
pathologic event in disorders such as elastosis per- 
forans serpiginosa and reactive perforating collage- 
nosis or as a secondary reactive process in dermatoses 
such as granuloma annulare and pseudoxanthoma 
elasticum. 
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Synthetic Dyes and Drug Entities 
We have seen the development of a synthetic dye industry and its removal from England to 
Germany and, to a lesser extent, to Switzerland. By accident, or by empirical chemistry, a 
number of pure organics had been synthesized; some had recently been found to be medicinally 
useful. These findings too were empirical. 
Several examples of such compounds will be noted here. Chloral had been prepared by 
Liebig in 1831, but was only introduced to medicine in 1869, when it was used by Oscar 
Liebrich (1939-1908) as a hypnotic. Acetylsalicylic acid (ASA) was first prepared in 1859 by 
Gilm, more than three decades after salicylic acid had been obtained by oxidation of salicin's 
aglycone. It was not until the mid 1870's that salicylates were shown to be antirheumatics and 
it would not be until 1898-99 that the acetyl derivative of salicylic acid would be resynthesized 
by Dresser and introduced to medicine as Aspirin. These two examples are chosen deliberately 
for another reason: to illustrate German use of the British patent system. 
Chloral and ASA are both subjects of patent applications by British agents acting for German 
subjects and interest, e.g. Liebrich as an individual in the Chloral patent; Dresser in the case of 
ASA assigning his interest to his employers. Liebrich's claim was for "the application and use 
of chloral or hydrate of chloral, or trichloracetic acids or salts or compounds of the same for 
the purpose of producing anoesthesia". Strangely he did not include trichloroethanol in his 
claim.-Paterson CH. Synthetic dyes and drug entities. Canad Bull Med Hist .  1984; 1 :  7 1 - 13. 
